Use of immunosuppression and subsequent cancer incidence: cohort study.

Buchanich JM, Newcomb CW, Washington TL, Foster CS, Sobrin L, Thorne JE, Jabs DA, Suhler EB, Rosenbaum JT, Sen HN, Levy-Clarke GA, Nussenblatt RB, Bhatt NP, Lowder CY, Goldstein DA, Leiderman YI, Acharya NR, Holland GN, Read RW, Dunn JP, Dreger KA, Artornsombudh P, Begum HA, Fitzgerald TD, Kothari S, Payal AR, Daniel E, Gangaputra SS, Kaçmaz RO, Liesegang TL, Pujari SS, Khachatryan N, Maghsoudlou A, Suga HK, Pak CM, Helzlsouer KJ, Kempen JH

Open source

DOI: 10.1136/bmjonc-2023-000037
Published: 2023
Container: BMJ oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjonc-2023-000037,
  title = {Use of immunosuppression and subsequent cancer incidence: cohort study.},
  author = {Buchanich JM and Newcomb CW and Washington TL and Foster CS and Sobrin L and Thorne JE and Jabs DA and Suhler EB and Rosenbaum JT and Sen HN and Levy-Clarke GA and Nussenblatt RB and Bhatt NP and Lowder CY and Goldstein DA and Leiderman YI and Acharya NR and Holland GN and Read RW and Dunn JP and Dreger KA and Artornsombudh P and Begum HA and Fitzgerald TD and Kothari S and Payal AR and Daniel E and Gangaputra SS and Kaçmaz RO and Liesegang TL and Pujari SS and Khachatryan N and Maghsoudlou A and Suga HK and Pak CM and Helzlsouer KJ and Kempen JH},
  year = {2023},
  journal = {BMJ oncology},
  doi = {10.1136/bmjonc-2023-000037},
  url = {https://doi.org/10.1136/bmjonc-2023-000037}
}

RIS

TY  - JOUR
TI  - Use of immunosuppression and subsequent cancer incidence: cohort study.
AU  - Buchanich JM
AU  - Newcomb CW
AU  - Washington TL
AU  - Foster CS
AU  - Sobrin L
AU  - Thorne JE
AU  - Jabs DA
AU  - Suhler EB
AU  - Rosenbaum JT
AU  - Sen HN
AU  - Levy-Clarke GA
AU  - Nussenblatt RB
AU  - Bhatt NP
AU  - Lowder CY
AU  - Goldstein DA
AU  - Leiderman YI
AU  - Acharya NR
AU  - Holland GN
AU  - Read RW
AU  - Dunn JP
AU  - Dreger KA
AU  - Artornsombudh P
AU  - Begum HA
AU  - Fitzgerald TD
AU  - Kothari S
AU  - Payal AR
AU  - Daniel E
AU  - Gangaputra SS
AU  - Kaçmaz RO
AU  - Liesegang TL
AU  - Pujari SS
AU  - Khachatryan N
AU  - Maghsoudlou A
AU  - Suga HK
AU  - Pak CM
AU  - Helzlsouer KJ
AU  - Kempen JH
PY  - 2023
JO  - BMJ oncology
DO  - 10.1136/bmjonc-2023-000037
UR  - https://doi.org/10.1136/bmjonc-2023-000037
ER  -

APA

JM, B., CW, N., TL, W., CS, F., L, S., JE, T., DA, J., EB, S., JT, R., HN, S., GA, L., RB, N., NP, B., CY, L., DA, G., YI, L., NR, A., GN, H., RW, R., JP, D., KA, D., P, A., HA, B., TD, F., S, K., AR, P., E, D., SS, G., RO, K., TL, L., SS, P., N, K., A, M., HK, S., CM, P., KJ, H., & JH, K. (2023). Use of immunosuppression and subsequent cancer incidence: cohort study.. BMJ oncology. https://doi.org/10.1136/bmjonc-2023-000037

Source records

pubmed · retrieved 2026-09-26T21:21:45.060Z